Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
153
NCT04080297
Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 10, 2014
Completion: Jul 28, 2014
NCT03518138
Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor
Phase: Phase 2
Start: Oct 24, 2018
Completion: Sep 9, 2020